Literature DB >> 27896567

FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells.

Vladimir S Shavva1,2, Alexandra M Bogomolova3, Artemy A Nikitin4,3, Ella B Dizhe4, Galina N Oleinikova4, Ivan A Lapikov5, Dmitry A Tanyanskiy4,6, Andrej P Perevozchikov4,5, Sergey V Orlov7,8.   

Abstract

Reactive oxygen species damage various cell components including DNA, proteins, and lipids, and these impairments could be a reason for severe human diseases including atherosclerosis. Forkhead box O1 (FOXO1), an important metabolic transcription factor, upregulates antioxidant and proapoptotic genes during oxidative stress. Apolipoprotein A-I (ApoA-I) forms high density lipoprotein (HDL) particles that are responsible for cholesterol transfer from peripheral tissues to liver for removal in bile in vertebrates. The main sources for plasma ApoA-I in mammals are liver and jejunum. Hepatic apoA-I transcription depends on a multitude of metabolic transcription factors. We demonstrate that ApoA-I synthesis and secretion are decreased during H2O2-induced oxidative stress in human hepatoma cell line HepG2. Here, we first show that FOXO1 binds to site B of apoA-I hepatic enhancer and downregulates apoA-I gene activity in HepG2 cells. Moreover, FOXO1 and LXRα transcription factors participate in H2O2-triggered downregulation of apoA-I gene together with Src, JNK, p38, and AMPK kinase cascades. Mutations of sites B or C as well as the administration of siRNAs against FOXO1 or LXRα to HepG2 cells abolished the hydrogen peroxide-mediated suppression of apoA-I gene.

Entities:  

Keywords:  Apolipoprotein A-I; FOXO1; Hydrogen peroxide; LXRα; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27896567      PMCID: PMC5225066          DOI: 10.1007/s12192-016-0749-6

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  67 in total

1.  Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription. Roles of forkhead and insulin response sequences.

Authors:  D Yeagley; S Guo; T Unterman; P G Quinn
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

2.  Differential tissue-specific expression of human apoA-I and apoA-II.

Authors:  T L Eggerman; J M Hoeg; M S Meng; A Tombragel; D Bojanovski; H B Brewer
Journal:  J Lipid Res       Date:  1991-05       Impact factor: 5.922

Review 3.  Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update.

Authors:  John M Kyriakis; Joseph Avruch
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

4.  Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.

Authors:  G Rena; S Guo; S C Cichy; T G Unterman; P Cohen
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

5.  Regulation of human apolipoprotein A-I gene expression by gramoxone.

Authors:  C Cuthbert; Z Wang; X Zhang; S P Tam
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

6.  Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity.

Authors:  D Schmoll; K S Walker; D R Alessi; R Grempler; A Burchell; S Guo; R Walther; T G Unterman
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

7.  NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.

Authors:  Atsuyuki Morishima; Nobutaka Ohkubo; Nobuji Maeda; Tetsuro Miki; Noriaki Mitsuda
Journal:  J Biol Chem       Date:  2003-07-25       Impact factor: 5.157

8.  Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta.

Authors:  Michael J Haas; Mohammad Horani; Amjad Mreyoud; Brian Plummer; Norman C W Wong; Arshag D Mooradian
Journal:  Biochim Biophys Acta       Date:  2003-10-13

9.  Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types.

Authors:  K N Sastry; U Seedorf; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

10.  Knockdown of AMP-activated protein kinase alpha 1 and alpha 2 catalytic subunits.

Authors:  Larissa Tangeman; Christopher N Wyatt; Thomas L Brown
Journal:  J RNAi Gene Silencing       Date:  2012-10-04
View more
  3 in total

1.  Tumor necrosis factor α stimulates endogenous apolipoprotein A-I expression and secretion by human monocytes and macrophages: role of MAP-kinases, NF-κB, and nuclear receptors PPARα and LXRs.

Authors:  Vladimir S Shavva; Denis A Mogilenko; Ekaterina V Nekrasova; Andrey S Trulioff; Igor V Kudriavtsev; Ekaterina E Larionova; Anna V Babina; Ella B Dizhe; Boris V Missyul; Sergey V Orlov
Journal:  Mol Cell Biochem       Date:  2018-02-13       Impact factor: 3.396

Review 2.  Diabetes and dyslipidemia: characterizing lipoprotein metabolism.

Authors:  G H Tomkin; D Owens
Journal:  Diabetes Metab Syndr Obes       Date:  2017-07-28       Impact factor: 3.168

3.  Association of genetic polymorphisms in SOD2, SOD3, GPX3, and GSTT1 with hypertriglyceridemia and low HDL-C level in subjects with high risk of coronary artery disease.

Authors:  Nisa Decharatchakul; Chatri Settasatian; Nongnuch Settasatian; Nantarat Komanasin; Upa Kukongviriyapan; Phongsak Intharaphet; Vichai Senthong
Journal:  PeerJ       Date:  2019-08-01       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.